Karl Hård
Net worth: 99 420 $ as of 30/05/2026
Net worth: 99 420 $ as of 30/05/2026
Karl J.
Hård is currently VP-Investor Relations & Business Development at Egetis Therapeutics AB since 2022.
Former positions include Investor Relations Contact at AstraZeneca PLC, Assistant Professor at the University of Leiden, Head-Investor Relations & Corporate Communications at Redx Pharma Plc from 2016 to 2017, and Head-Investor Relations & Communications at Kiadis Pharma NV from 2017 to 2018.
Education includes a doctorate from the University of Utrecht and graduate studies at the University of Helsinki.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/12/2025 | 150,982 ( 0.03% ) | 99 420 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| EGETIS THERAPEUTICS AB | Investor Relations Contact | 31/01/2022 |
| Companies | Position | End |
|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 30/12/2018 |
| REDX PHARMA LTD | Investor Relations Contact | 01/07/2017 |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Redx Pharma Plc
Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions